Skip to main content

Table 1 Presentation characteristics of SJIA versus NB patients

From: Neuroblastoma versus systemic JIA – a diagnostic dilemma

Variables sJIA (65) Neuroblastoma (89)  
Age (years) 7.2 ± 4.7 3.0 ± 3.5 <0.0001
Gender Famle 51% Female 42% 0.26
  Male 49% Male 58%  
Race White 91% White 85% 0.86
  Black 6% Black 7%  
  Hispanic 3% Hispanic 3%  
   Other 5%  
Fever present (0=no, 1=yes) 45/45 (100%) 12/71 (18%) <0.0001
Time to diagnosis (months) 1.5 (65) 1.2 (78) 0.18
Arthritis 51/65 (78%) 1/71 (1%) <0.0001
Rash 53/64 (83%) 2/71 (3%) <0.0001
Abdominal mass 1/65 (2%) 29/71 (41%) 0.0001
Weight loss 11/65 (17%) 5/71 (7%) 0.07
Gait disturbance or extremity pain 45/65 (41%) 13/73 (18%) <0.0001
Neuroblastoma stage n/a Stage 1 = 19/62 (31%) n/a
   Stage 2 = 3/62 (5%)  
   Stage 3 = 9/62(14%)  
   Stage 4 =31/62 (50%)  
LDH (units/L) 637 ± 530 (35) 1842 ± 2410 (46) 0.005
Uric Acid (mg/dL) 3.3 ± 1.2 (22) 5.1 ± 2.9 (34) 0.005
Crp (mg/dL) 14.9 ± 25.3 (26) 10.2 ± 7.2 (4) 0.71
ESR (mm/hr) 81.6 ± 36.3 (58) 61.7 ± 46.0 (13) 0.09
PLT count 464,016 ± 173,148 (62) 327,419 ± 136,488 (62) <0.00001
WBC 18,881 ± 11,449 (63) 10,484 ± 5,892 (68) <0.00001
HGB (g.dL) 10.2 ± 1.80 (62) 10.3 ± 2.46 (67) 0.97
Neurtophil % 73 ± 14 (57) 0.49 ± 0.17 (64) <0.00001
Lymphocyte % 17 ± 10 (47) 40 ± 17 (64) <0.00001
Ferntin (ng/mL) 4,016 ± 6, 135 (50) 159 ± 205 (29) 0.001
D-Dimer elevated 34/36 (94%) 2/2 (100%) 0.73
Aldolase 15.6 ± 11.4 (28) 8.85 ± 1.01 (2) 0.42